Results 41 to 50 of about 5,007,317 (352)

Evaluation of Malnutrition and Quality of Life in Patients Treated for Oral and Oropharyngeal Cancer

open access: yesTheScientificWorldJournal, 2021
Background Oral and oropharyngeal cancer is a debilitating disease with high morbidity and mortality. Depending on the site and extent of the involvement of the cancer and the type of treatment modality, these patients can develop pain, trismus ...
Shruthi Pingili   +4 more
semanticscholar   +1 more source

OROPHARYNGEAL CANCER MORTALITY ACCORDING TO THE HUMAN DEVELOPMENT INDEX IN THE METROPOLITAN REGION OF CHILE, 2002-2014

open access: yesJournal of Oral Research, 2018
To determine mortality rates for oropharyngeal cancer according to the Human Development Index (HDI) per district in the Metropolitan Region (RM), Santiago, Chile, between 2002 and 2014. Materials and Methods: An ecological study was carried out.
Vicente Livacic   +3 more
doaj   +1 more source

Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial

open access: yesThe Lancet, 2019
Summary Background The incidence of human papillomavirus (HPV)-positive oropharyngeal cancer, a disease affecting younger patients, is rapidly increasing.
H. Mehanna   +80 more
semanticscholar   +1 more source

Phase 1b/2a trial of the superoxide dismutase mimetic GC4419 to reduce chemoradiotherapy-induced oral mucositis in patients with oral cavity or oropharyngeal carcinoma [PDF]

open access: yes, 2018
PURPOSE: To assess the safety of the superoxide dismutase mimetic GC4419 in combination with radiation and concurrent cisplatin for patients with oral cavity or oropharyngeal cancer (OCC) and to assess the potential of GC4419 to reduce severe oral ...
Adkins, Douglas   +13 more
core   +2 more sources

Knowledge and risk perception of oral cavity and oropharyngeal cancer among non-medical university students

open access: yesJournal of Otolaryngology - Head and Neck Surgery, 2016
Background To assess non-medical university students’ knowledge and perceived risk of developing oral cavity and oropharyngeal cancer. Methods A cross-sectional survey was conducted among non-medical students of a private Midwestern university in the ...
Nosayaba Osazuwa-Peters, Nhial T. Tutlam
doaj   +1 more source

Psychometric Properties of Questionnaires on Functional Health Status in Oropharyngeal Dysphagia: A Systematic Literature Review [PDF]

open access: yes, 2014
Introduction. Questionnaires on Functional Health Status (FHS) are part of the assessment of oropharyngeal dysphagia. Objective. To conduct a systematic review of the literature on the psychometric properties of English-language FHS questionnaires in ...
Cordier, Reinie   +3 more
core   +5 more sources

Analysis of radiation-induced cell death in head and neck squamous cell carcinoma and rat liver maintained in microfluidic devices [PDF]

open access: yes, 2013
Objective The aim of this study was to investigate how head and neck squamous cell carcinoma (HNSCC) tissue biopsies maintained in a pseudo in vivo environment within a bespoke microfluidic device respond to radiation treatment.
Burcombe R   +27 more
core   +2 more sources

Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial.

open access: yesThe Lancet, 2019
BACKGROUND Patients with human papillomavirus (HPV)-positive oropharyngeal squamous cell carcinoma have high survival when treated with radiotherapy plus cisplatin.
M. Gillison   +27 more
semanticscholar   +1 more source

National and subnational plans for primary prevention and early detection of oral and oropharyngeal cancer: a scoping review [PDF]

open access: yesCadernos de Saúde Pública
This scoping review maps primary prevention and early detection strategies for oral and oropharyngeal cancer across national cancer plans and noncommunicable disease plans from all World Health Organization Member States. Following PRISMA-ScR guidelines,
Marcia Frias Pinto Marinho   +8 more
doaj   +1 more source

Transforming Growth Factor Alpha Stimulation of Mucosal Tissue Cultures from Head and Neck Squamous Cell Carcinoma Patients Increases Chemoresistance to Cisplatin [PDF]

open access: yes, 2010
The monoclonal epidermal growth factor receptor ( EGFR) antibody cetuximab (Erbitux(TM)) was recently approved by the European Medicines Agency for the treatment of recurrent and/or metastatic head and neck squamous cell carcinoma (HNSCC) in combination ...
Baumeister, Philipp   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy